Kathryn Williams - Concepedia

Author

Kathryn Williams

Also Known As

K Williams, K. H. Williams, K. Williams, K.H. Williams, Kathryn H Williams, Kathryn H. Williams, Kathryn Helen Williams, Kathryn Williams

Publications

995

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Royal Prince Alfred Hospital Nepean Hospital Westmead Hospital UNSW Sydney

About

Kathryn Williams is an author at The University of Sydney specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	265
2	Public Health	4	4	183
3	Health Sciences	2	2	78
4	Engineering	1	1	20
5	Nursing	1	1	20

Kathryn Williams

Publications

523

Citations

H-Index

Page 1

	Year	Citations
The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study—a 3-mo randomized controlled trial Nicholas R. Fuller, Ian D. Caterson, Amanda Sainsbury, American Journal of Clinical Nutrition NutritionDiabetes Epidemiology3-Mo RandomizedCardiovascular DiseaseHigh-egg Diet	2015	114
Circulating dipeptidyl peptidase‐4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non‐alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross‐sectional study Kathryn Williams, Ana Júlia Vieira de Ribeiro, Emilia Prakoso, Journal of Diabetes	2014	53
Clinical Obesity Services in Public Hospitals in Australia: a position statement based on expert consensus Evan Atlantis, Nic Kormas, Katherine Samaras, Clinical Obesity	2018	46
An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes Kathryn Williams, Kharis Burns, Maria Constantino, Journal of Diabetes and its Complications Metabolic SyndromeLiver FibrosisHepatologyLiver PhysiologyDiabetes	2015	42
Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study—randomized weight-loss and follow-up phase Nicholas R. Fuller, Amanda Sainsbury, Ian D. Caterson, American Journal of Clinical Nutrition ObesityMetabolic SyndromeNutritionDiabetes EpidemiologyCardiovascular Disease	2018	38
Evaluation of a national surveillance unit Madlen Gazarian, Kathryn Williams, Elizabeth Elliott, Archives of Disease in Childhood	1999	36
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity Kathryn Williams, A.J. Viera de Ribeiro, Emilia Prakoso, Diabetes Research and Clinical Practice ImmunologyPathologyFatty Liver DiseaseInsulin SignalingObesity	2015	36
Pathways to care for alcohol use disorders Martin Commander, S. M. Odell, Kathryn Williams, Journal of Public Health	1999	26
Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study Kathryn Williams, David Sullivan, Geoffrey C. Nicholson, Metabolism Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyEvent LoweringMedicine	2015	24
Changes in physical activity during a weight loss intervention and follow‐up: a randomized controlled trial Nicholas R. Fuller, Kathryn Williams, Rupendra Shrestha, Clinical Obesity	2014	20

Page 1